DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zestoretic (Lisinopril / Hydrochlorothiazide) - Hypertension - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Hypertension (11)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Zestoretic (Lisinopril / Hydrochlorothiazide) where reactions include hypertension. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Zestoretic side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-15

Patient: female, weighing 89.4 kg (196.7 pounds)

Reactions: Dysarthria, Polymedication, Mental Status Changes, Headache, Hypertension, Asthenia, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lexapro
    Administration route: Oral
    Indication: Post-Traumatic Stress Disorder

Ambien
    Administration route: Oral
    Indication: Insomnia

Lyrica
    Administration route: Oral
    Indication: Fibromyalgia

Clonazepam
    Administration route: Oral
    Indication: Bipolar Disorder

Ibuprofen
    Administration route: Oral
    Indication: Fibromyalgia

Placebo
    Administration route: Oral
    Start date: 2008-11-29
    End date: 2008-12-24

Lexapro
    Administration route: Oral
    Indication: Bipolar Disorder

Robaxin
    Indication: Fibromyalgia

Zestoretic
    Dosage: 20/12.5 daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-12-04

Desvenlafaxine Succinate Monohydrate
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2008-09-09
    End date: 2008-11-22

Placebo
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2008-09-09
    End date: 2008-11-22

Loratadine
    Administration route: Oral
    Indication: Seasonal Allergy

Vicodin
    Dosage: 5/500 as needed
    Administration route: Oral
    Indication: Fibromyalgia

Vivelle
    Indication: Hormone Replacement Therapy

Desvenlafaxine Succinate Monohydrate
    Administration route: Oral
    Start date: 2008-11-29
    End date: 2008-12-24

Abilify
    Administration route: Oral
    Indication: Bipolar I Disorder

Fluticasone
    Indication: Seasonal Allergy



Possible Zestoretic side effects in female

Reported by a physician from United States on 2012-03-13

Patient: female, weighing 89.4 kg (196.7 pounds)

Reactions: Dysarthria, Polymedication, Mental Status Changes, Condition Aggravated, Hypertension, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abilify
    Dosage: 15 mg, 2x/day
    Administration route: Oral
    Indication: Bipolar I Disorder

Blinded Desvenlafaxine Succinate Monohydrate
    Dosage: blinded therapy daily
    Administration route: Oral
    Start date: 2008-11-29
    End date: 2008-12-24

Lexapro
    Dosage: 20 mg, 1x/day
    Administration route: Oral
    Indication: Post-Traumatic Stress Disorder

Fluticasone
    Dosage: 2 sprays daily route: in
    Indication: Seasonal Allergy

Blinded Placebo
    Dosage: blinded therapy daily
    Administration route: Oral
    Start date: 2008-11-29
    End date: 2008-12-24

Lyrica
    Dosage: 75 mg, 1x/day
    Administration route: Oral
    Indication: Fibromyalgia

Robaxin
    Dosage: 750 mg, 3x/day
    Administration route: Oral
    Indication: Fibromyalgia

Clonazepam
    Dosage: 1 mg, 2x/day
    Administration route: Oral
    Indication: Bipolar Disorder

Vicodin
    Dosage: 5/500 prn
    Administration route: Oral
    Indication: Fibromyalgia

Blinded Placebo
    Dosage: blinded therapy daily
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2008-09-09
    End date: 2008-11-22

Loratadine
    Dosage: 10 mg, 1x/day
    Administration route: Oral
    Indication: Seasonal Allergy

Robaxin
    Dosage: unknown

Lexapro
    Indication: Bipolar Disorder

Vivelle
    Dosage: 0.1 mg, unk
    Indication: Hormone Replacement Therapy

Ibuprofen
    Dosage: 800 mg, 3x/day
    Administration route: Oral
    Indication: Fibromyalgia

Ambien
    Dosage: 10 mg, 1x/day
    Administration route: Oral
    Indication: Insomnia

Blinded Desvenlafaxine Succinate Monohydrate
    Dosage: blinded therapy daily
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2008-09-09
    End date: 2008-11-22

Blinded NO Subject Drug
    Dosage: blinded therapy daily
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2008-09-09
    End date: 2008-11-22

Zestoretic
    Dosage: 20/12.5 daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-12-04

Blinded NO Subject Drug
    Dosage: blinded therapy daily
    Administration route: Oral
    Start date: 2008-11-29
    End date: 2008-12-24



Possible Zestoretic side effects in 72 year old female

Reported by a consumer/non-health professional from United States on 2012-02-13

Patient: 72 year old female, weighing 62.1 kg (136.6 pounds)

Reactions: Urethral Cancer, Respiratory Disorder, Tinnitus, Ear Haemorrhage, Anaphylactic Reaction, Deafness, Headache, Cardiac Disorder, Cardiomegaly, Balance Disorder, Blindness Unilateral, Tympanic Membrane Perforation, Bladder Cancer, Nasal Congestion, Wound Infection, Ulcer, Accident, Ischaemia, Renal Colic, Pain, Speech Disorder, Eye Haemorrhage, Overdose, Coronary Artery Occlusion, Dysgraphia, Heart Rate Irregular, Transient Ischaemic Attack, Kidney Infection, Myocardial Infarction, Eye Disorder, Decreased Appetite, Renal Disorder, Cerebral Atrophy, Purpura, Cerebrovascular Accident, Eye Pain, Arrhythmia, Renal Failure, Ureteric Cancer, Diarrhoea, Carditis, Bladder Disorder, Hypertension

Drug(s) suspected as cause:
Tenormin
    Administration route: Oral
    Indication: Hypertension
    Start date: 2005-12-01
    End date: 2008-05-01

Zestoretic
    Dosage: 10/12.5 mg
    Administration route: Oral
    Indication: Hypertension
    Start date: 2002-01-01
    End date: 2005-12-01

Diovan
    Start date: 2009-09-01
    End date: 2011-10-01

Zestoretic
    Administration route: Oral

Avastin

Other drugs received by patient: Atenolol / Chlorthiadone(mylan); Vitamin TAB; Aspirin; Bactrim; Sulfadiazine



Possible Zestoretic side effects in 72 year old female

Reported by a consumer/non-health professional from United States on 2012-01-17

Patient: 72 year old female, weighing 62.1 kg (136.6 pounds)

Reactions: Respiratory Disorder, Urethral Cancer, Tinnitus, Ear Haemorrhage, Anaphylactic Reaction, Deafness, Headache, Cardiac Disorder, Cardiomegaly, Balance Disorder, Blindness Unilateral, Tympanic Membrane Perforation, Bladder Cancer, Wound Infection, Nasal Congestion, Ulcer, Accident, Ischaemia, Renal Colic, Pain, Speech Disorder, Eye Haemorrhage, Overdose, Coronary Artery Occlusion, Heart Rate Irregular, Eye Disorder, Myocardial Infarction, Kidney Infection, Transient Ischaemic Attack, Decreased Appetite, Renal Disorder, Cerebral Atrophy, Purpura, Cerebrovascular Accident, Arrhythmia, Eye Pain, Ureteric Cancer, Renal Failure, Diarrhoea, Carditis, Bladder Disorder, Hypertension

Drug(s) suspected as cause:
Tenormin
    Administration route: Oral
    Indication: Hypertension
    Start date: 2005-12-01
    End date: 2008-05-01

Zestoretic
    Dosage: 10/12.5 mg
    Administration route: Oral
    Indication: Hypertension
    Start date: 2002-01-01
    End date: 2005-12-01

Diovan
    Start date: 2009-09-01
    End date: 2011-10-01

Avastin

Other drugs received by patient: Sulfadiazine; Bactrim; Aspirin; Vitamin TAB; Atenolol / Chlorthiadone(mylan)



Possible Zestoretic side effects in 72 year old female

Reported by a individual with unspecified qualification from United States on 2011-12-30

Patient: 72 year old female, weighing 62.1 kg (136.6 pounds)

Reactions: Tinnitus, Respiratory Disorder, Ear Haemorrhage, Anaphylactic Reaction, Deafness, Headache, Cardiomegaly, Cardiac Disorder, Balance Disorder, Tympanic Membrane Perforation, Bladder Cancer, Nasal Congestion, Ulcer, Accident, Ischaemia, Renal Colic, Pain, Eye Haemorrhage, Speech Disorder, Overdose, Coronary Artery Occlusion, Heart Rate Irregular, Eye Disorder, Transient Ischaemic Attack, Kidney Infection, Myocardial Infarction, Decreased Appetite, Renal Disorder, Cerebral Atrophy, Purpura, Cerebrovascular Accident, Arrhythmia, Eye Pain, Ureteric Cancer, Renal Failure, Diarrhoea, Bladder Disorder, Blindness, Hypertension, Infection

Drug(s) suspected as cause:
Avastin

Tenormin
    Administration route: Oral
    Indication: Hypertension

Zestoretic
    Dosage: 10/12.5 mg
    Administration route: Oral
    Indication: Hypertension
    Start date: 2002-01-01
    End date: 2005-11-23

Diovan

Other drugs received by patient: Atenolol / Chlorthiadone(mylan); Aspirin; Bactrim; Vitamin TAB; Sulfadiazine



Possible Zestoretic side effects in 72 year old female

Reported by a consumer/non-health professional from United States on 2011-12-23

Patient: 72 year old female, weighing 62.1 kg (136.6 pounds)

Reactions: Respiratory Disorder, Tinnitus, Ear Haemorrhage, Anaphylactic Reaction, Deafness, Headache, Cardiac Disorder, Balance Disorder, Tympanic Membrane Perforation, Bladder Cancer, Ulcer, Accident, Dysphonia, Renal Colic, Pain, Eye Haemorrhage, Overdose, Heart Rate Irregular, Myocardial Infarction, Eye Disorder, Transient Ischaemic Attack, Kidney Infection, Decreased Appetite, Renal Disorder, Cerebral Atrophy, Purpura, Cerebrovascular Accident, Eye Pain, Renal Failure, Ureteric Cancer, Diarrhoea, Bladder Disorder, Hypertension, Infection

Drug(s) suspected as cause:
Avastin

Tenormin
    Administration route: Oral
    Indication: Hypertension

Diovan

Zestoretic
    Dosage: 10/12.5 mg
    Administration route: Oral
    Indication: Hypertension
    Start date: 2002-01-01
    End date: 2005-11-23

Other drugs received by patient: Atenolol / Chlorthiadone(mylan); Vitamin TAB; Sulfadiazine; Bactrim; Aspirin



Possible Zestoretic side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-23

Patient: female, weighing 89.4 kg (196.7 pounds)

Reactions: Dysarthria, Polymedication, Mental Status Changes, Headache, Hypertension, Asthenia, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Desvenlafaxine Succinate Monohydrate
    Administration route: Oral
    Start date: 2008-09-09
    End date: 2008-11-22

Lexapro
    Indication: Ill-Defined Disorder

Fluticasone Furoate
    Indication: Ill-Defined Disorder

Loratadine
    Indication: Ill-Defined Disorder

Vicodin
    Dosage: 5/500 as needed
    Indication: Ill-Defined Disorder

Ambien
    Administration route: Oral
    Indication: Ill-Defined Disorder

Lyrica
    Indication: Ill-Defined Disorder

Placebo
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2008-09-09
    End date: 2008-11-22

Abilify
    Indication: Ill-Defined Disorder

Vivelle
    Indication: Ill-Defined Disorder

Zestoretic
    Dosage: 20/12.5 daily
    Indication: Ill-Defined Disorder

Desvenlafaxine Succinate Monohydrate
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2008-11-29
    End date: 2008-12-24

Robaxin
    Indication: Ill-Defined Disorder

Ibuprofen
    Indication: Ill-Defined Disorder

Placebo
    Administration route: Oral
    Start date: 2008-11-29
    End date: 2008-12-24

Clonazepam
    Indication: Ill-Defined Disorder



Possible Zestoretic side effects in female

Reported by a physician from United States on 2011-12-20

Patient: female, weighing 89.4 kg (196.7 pounds)

Reactions: Dysarthria, Polymedication, Mental Status Changes, Condition Aggravated, Hypertension, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Desvenlafaxine Succinate Monohydrate
    Dosage: blinded therapy daily
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2008-09-09
    End date: 2008-11-22

Blinded NO Subject Drug
    Dosage: blinded therapy daily
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2008-09-09
    End date: 2008-11-22

Blinded Desvenlafaxine Succinate Monohydrate
    Dosage: blinded therapy daily
    Administration route: Oral
    Start date: 2008-11-29
    End date: 2008-12-24

Ibuprofen
    Dosage: 800 mg, 3x/day

Robaxin
    Dosage: unknown

Blinded Placebo
    Dosage: blinded therapy daily
    Administration route: Oral
    Start date: 2008-11-29
    End date: 2008-12-24

Clonazepam
    Dosage: 1 mg, 2x/day

Lexapro
    Dosage: 20 mg, 1x/day

Vicodin
    Dosage: 5/500 prn

Ambien
    Dosage: 10 mg, 1x/day
    Administration route: Oral

Blinded Placebo
    Dosage: blinded therapy daily
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2008-09-09
    End date: 2008-11-22

Blinded NO Subject Drug
    Dosage: blinded therapy daily
    Administration route: Oral
    Start date: 2008-11-29
    End date: 2008-12-24

Zestoretic
    Dosage: 20/12.5 daily

Lyrica
    Dosage: 75 mg, 1x/day

Fluticasone Furoate
    Dosage: 2 sprays daily

Abilify
    Dosage: 15 mg, 2x/day

Vivelle
    Dosage: 0.1 mg, unk

Loratadine
    Dosage: 10 mg, 1x/day

Robaxin
    Dosage: 750 mg, 3x/day
    Administration route: Oral



Possible Zestoretic side effects in female

Reported by a physician from United States on 2011-12-19

Patient: female, weighing 89.4 kg (196.7 pounds)

Reactions: Dysarthria, Polymedication, Mental Status Changes, Condition Aggravated, Hypertension, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abilify
    Dosage: 15 mg, 2x/day

Blinded Placebo
    Dosage: blinded therapy daily
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2008-09-09
    End date: 2008-11-22

Fluticasone Propionate
    Dosage: 2 sprays daily

Vicodin
    Dosage: 5/500 prn

Ambien
    Dosage: 10 mg, 1x/day
    Administration route: Oral

Blinded Desvenlafaxine Succinate Monohydrate
    Dosage: blinded therapy daily
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2008-09-09
    End date: 2008-11-22

Lyrica
    Dosage: 75 mg, 1x/day

Vivelle
    Dosage: 0.1 mg, unk

Blinded Desvenlafaxine Succinate Monohydrate
    Dosage: blinded therapy daily
    Administration route: Oral
    Start date: 2008-11-29
    End date: 2008-12-24

Blinded NO Subject Drug
    Dosage: blinded therapy daily
    Administration route: Oral
    Start date: 2008-11-29
    End date: 2008-12-24

Robaxin
    Dosage: 750 mg, 3x/day
    Administration route: Oral

Blinded Placebo
    Dosage: blinded therapy daily
    Administration route: Oral
    Start date: 2008-11-29
    End date: 2008-12-24

Ibuprofen
    Dosage: 800 mg, 3x/day

Clonazepam
    Dosage: 1 mg, 2x/day

Loratadine
    Dosage: 10 mg, 1x/day

Zestoretic
    Dosage: 20/12.5 daily

Blinded NO Subject Drug
    Dosage: blinded therapy daily
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2008-09-09
    End date: 2008-11-22

Lexapro
    Dosage: 20 mg, 1x/day



Possible Zestoretic side effects in female

Reported by a physician from United States on 2011-12-16

Patient: female, weighing 89.4 kg (196.7 pounds)

Reactions: Dysarthria, Polymedication, Condition Aggravated, Mental Status Changes, Hypertension, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lexapro
    Dosage: 20 mg, 1x/day

Vivelle
    Dosage: 0.1 mg, unk

Blinded NO Subject Drug
    Dosage: blinded therapy daily
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2008-09-09
    End date: 2008-11-22

Blinded Desvenlafaxine Succinate Monohydrate
    Dosage: blinded therapy daily
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2008-09-09
    End date: 2008-11-22

Blinded NO Subject Drug
    Dosage: blinded therapy daily
    Administration route: Oral
    Start date: 2008-11-29
    End date: 2008-12-24

Blinded Placebo
    Dosage: blinded therapy daily
    Administration route: Oral
    Start date: 2008-11-29
    End date: 2008-12-24

Loratadine
    Dosage: 10 mg, 1x/day

Robaxin
    Dosage: unknown

Abilify
    Dosage: 15 mg, 2x/day

Ibuprofen
    Dosage: 800 mg, 3x/day

Clonazepam
    Dosage: 1 mg, 2x/day

Fluticasone
    Dosage: 2 sprays daily

Zestoretic
    Dosage: 20/12.5 daily

Ambien
    Dosage: 10 mg, 1x/day
    Administration route: Oral

Lyrica
    Dosage: 75 mg, 1x/day

Robaxin
    Dosage: 750 mg, 3x/day
    Administration route: Oral

Blinded Placebo
    Dosage: blinded therapy daily
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2008-09-09
    End date: 2008-11-22

Blinded Desvenlafaxine Succinate Monohydrate
    Dosage: blinded therapy daily
    Administration route: Oral
    Start date: 2008-11-29
    End date: 2008-12-24

Vicodin
    Dosage: 5/500 prn



Possible Zestoretic side effects in 72 year old female

Reported by a consumer/non-health professional from United States on 2011-11-07

Patient: 72 year old female, weighing 62.1 kg (136.6 pounds)

Reactions: Tinnitus, Ear Haemorrhage, Pain, Deafness, Headache, Cardiac Disorder, Eye Haemorrhage, Overdose, Balance Disorder, Heart Rate Irregular, Tympanic Membrane Perforation, Transient Ischaemic Attack, Bladder Cancer, Renal Disorder, Cerebral Atrophy, Cerebrovascular Accident, Ulcer, Renal Failure, Dysphonia, Visual Impairment, Bladder Disorder, Hypertension

Drug(s) suspected as cause:
Atenolol
    Administration route: Oral
    Indication: Hypertension

Zestoretic
    Dosage: 10/12.5 mg
    Administration route: Oral
    Indication: Hypertension
    Start date: 2002-01-01
    End date: 2005-11-23

Other drugs received by patient: Atenolol / Chlorthiadone(mylan); Sulfa; Bactrim

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017